Global and United States Nuclear Receptor ROR-Gamma Market Insights, Forecast to 2026
SKU ID : QYR-16433829 | Publishing Date : 16-Sep-2020 | No. of pages : 144
Detailed TOC of Global and United States Nuclear Receptor ROR-Gamma Market Insights, Forecast to 2026
1 Study Coverage1.1 Nuclear Receptor ROR-Gamma Product Introduction
1.2 Market Segments
1.3 Key Nuclear Receptor ROR-Gamma Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Type
1.4.2 VPR-66
1.4.3 INV-17
1.4.4 GSK-2981278
1.4.5 BBI-6000
1.4.6 Others
1.5 Market by Application
1.5.1 Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Nuclear Receptor ROR-Gamma Market Size, Estimates and Forecasts
2.1.1 Global Nuclear Receptor ROR-Gamma Revenue 2015-2026
2.1.2 Global Nuclear Receptor ROR-Gamma Sales 2015-2026
2.2 Global Nuclear Receptor ROR-Gamma, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Nuclear Receptor ROR-Gamma Historical Market Size by Region (2015-2020)
2.3.1 Global Nuclear Receptor ROR-Gamma Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Nuclear Receptor ROR-Gamma Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Nuclear Receptor ROR-Gamma Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Nuclear Receptor ROR-Gamma Sales Forecast by Region (2021-2026)
2.4.2 Global Nuclear Receptor ROR-Gamma Revenue Forecast by Region (2021-2026)
3 Global Nuclear Receptor ROR-Gamma Competitor Landscape by Players
3.1 Global Top Nuclear Receptor ROR-Gamma Sales by Manufacturers
3.1.1 Global Nuclear Receptor ROR-Gamma Sales by Manufacturers (2015-2020)
3.1.2 Global Nuclear Receptor ROR-Gamma Sales Market Share by Manufacturers (2015-2020)
3.2 Global Nuclear Receptor ROR-Gamma Manufacturers by Revenue
3.2.1 Global Nuclear Receptor ROR-Gamma Revenue by Manufacturers (2015-2020)
3.2.2 Global Nuclear Receptor ROR-Gamma Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Nuclear Receptor ROR-Gamma Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Nuclear Receptor ROR-Gamma Revenue in 2019
3.2.5 Global Nuclear Receptor ROR-Gamma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Nuclear Receptor ROR-Gamma Price by Manufacturers
3.4 Global Nuclear Receptor ROR-Gamma Manufacturing Base Distribution, Product Types
3.4.1 Nuclear Receptor ROR-Gamma Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nuclear Receptor ROR-Gamma Product Type
3.4.3 Date of International Manufacturers Enter into Nuclear Receptor ROR-Gamma Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020)
4.1.1 Global Nuclear Receptor ROR-Gamma Sales by Type (2015-2020)
4.1.2 Global Nuclear Receptor ROR-Gamma Revenue by Type (2015-2020)
4.1.3 Nuclear Receptor ROR-Gamma Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Nuclear Receptor ROR-Gamma Market Size Forecast by Type (2021-2026)
4.2.1 Global Nuclear Receptor ROR-Gamma Sales Forecast by Type (2021-2026)
4.2.2 Global Nuclear Receptor ROR-Gamma Revenue Forecast by Type (2021-2026)
4.2.3 Nuclear Receptor ROR-Gamma Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Nuclear Receptor ROR-Gamma Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020)
5.1.1 Global Nuclear Receptor ROR-Gamma Sales by Application (2015-2020)
5.1.2 Global Nuclear Receptor ROR-Gamma Revenue by Application (2015-2020)
5.1.3 Nuclear Receptor ROR-Gamma Price by Application (2015-2020)
5.2 Nuclear Receptor ROR-Gamma Market Size Forecast by Application (2021-2026)
5.2.1 Global Nuclear Receptor ROR-Gamma Sales Forecast by Application (2021-2026)
5.2.2 Global Nuclear Receptor ROR-Gamma Revenue Forecast by Application (2021-2026)
5.2.3 Global Nuclear Receptor ROR-Gamma Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Nuclear Receptor ROR-Gamma Market Size YoY Growth 2015-2026
6.1.1 United States Nuclear Receptor ROR-Gamma Sales YoY Growth 2015-2026
6.1.2 United States Nuclear Receptor ROR-Gamma Revenue YoY Growth 2015-2026
6.1.3 United States Nuclear Receptor ROR-Gamma Market Share in Global Market 2015-2026
6.2 United States Nuclear Receptor ROR-Gamma Market Size by Players (International and Local Players)
6.2.1 United States Top Nuclear Receptor ROR-Gamma Players by Sales (2015-2020)
6.2.2 United States Top Nuclear Receptor ROR-Gamma Players by Revenue (2015-2020)
6.3 United States Nuclear Receptor ROR-Gamma Historic Market Review by Type (2015-2020)
6.3.1 United States Nuclear Receptor ROR-Gamma Sales Market Share by Type (2015-2020)
6.3.2 United States Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2015-2020)
6.3.3 United States Nuclear Receptor ROR-Gamma Price by Type (2015-2020)
6.4 United States Nuclear Receptor ROR-Gamma Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Nuclear Receptor ROR-Gamma Sales Forecast by Type (2021-2026)
6.4.2 United States Nuclear Receptor ROR-Gamma Revenue Forecast by Type (2021-2026)
6.4.3 United States Nuclear Receptor ROR-Gamma Price Forecast by Type (2021-2026)
6.5 United States Nuclear Receptor ROR-Gamma Historic Market Review by Application (2015-2020)
6.5.1 United States Nuclear Receptor ROR-Gamma Sales Market Share by Application (2015-2020)
6.5.2 United States Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2015-2020)
6.5.3 United States Nuclear Receptor ROR-Gamma Price by Application (2015-2020)
6.6 United States Nuclear Receptor ROR-Gamma Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Nuclear Receptor ROR-Gamma Sales Forecast by Application (2021-2026)
6.6.2 United States Nuclear Receptor ROR-Gamma Revenue Forecast by Application (2021-2026)
6.6.3 United States Nuclear Receptor ROR-Gamma Price Forecast by Application (2021-2026)
7 North America
7.1 North America Nuclear Receptor ROR-Gamma Market Size YoY Growth 2015-2026
7.2 North America Nuclear Receptor ROR-Gamma Market Facts & Figures by Country
7.2.1 North America Nuclear Receptor ROR-Gamma Sales by Country (2015-2020)
7.2.2 North America Nuclear Receptor ROR-Gamma Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Nuclear Receptor ROR-Gamma Market Size YoY Growth 2015-2026
8.2 Europe Nuclear Receptor ROR-Gamma Market Facts & Figures by Country
8.2.1 Europe Nuclear Receptor ROR-Gamma Sales by Country
8.2.2 Europe Nuclear Receptor ROR-Gamma Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Nuclear Receptor ROR-Gamma Market Size YoY Growth 2015-2026
9.2 Asia Pacific Nuclear Receptor ROR-Gamma Market Facts & Figures by Country
9.2.1 Asia Pacific Nuclear Receptor ROR-Gamma Sales by Region (2015-2020)
9.2.2 Asia Pacific Nuclear Receptor ROR-Gamma Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Nuclear Receptor ROR-Gamma Market Size YoY Growth 2015-2026
10.2 Latin America Nuclear Receptor ROR-Gamma Market Facts & Figures by Country
10.2.1 Latin America Nuclear Receptor ROR-Gamma Sales by Country
10.2.2 Latin America Nuclear Receptor ROR-Gamma Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Nuclear Receptor ROR-Gamma Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Nuclear Receptor ROR-Gamma Market Facts & Figures by Country
11.2.1 Middle East and Africa Nuclear Receptor ROR-Gamma Sales by Country
11.2.2 Middle East and Africa Nuclear Receptor ROR-Gamma Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 4SC AG
12.1.1 4SC AG Corporation Information
12.1.2 4SC AG Description and Business Overview
12.1.3 4SC AG Sales, Revenue and Gross Margin (2015-2020)
12.1.4 4SC AG Nuclear Receptor ROR-Gamma Products Offered
12.1.5 4SC AG Recent Development
12.2 Advinus Therapeutics Ltd.
12.2.1 Advinus Therapeutics Ltd. Corporation Information
12.2.2 Advinus Therapeutics Ltd. Description and Business Overview
12.2.3 Advinus Therapeutics Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Products Offered
12.2.5 Advinus Therapeutics Ltd. Recent Development
12.3 Arrien Pharmaceuticals, LLC
12.3.1 Arrien Pharmaceuticals, LLC Corporation Information
12.3.2 Arrien Pharmaceuticals, LLC Description and Business Overview
12.3.3 Arrien Pharmaceuticals, LLC Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Products Offered
12.3.5 Arrien Pharmaceuticals, LLC Recent Development
12.4 Aurigene Discovery Technologies Limited
12.4.1 Aurigene Discovery Technologies Limited Corporation Information
12.4.2 Aurigene Discovery Technologies Limited Description and Business Overview
12.4.3 Aurigene Discovery Technologies Limited Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Products Offered
12.4.5 Aurigene Discovery Technologies Limited Recent Development
12.5 Biogen, Inc.
12.5.1 Biogen, Inc. Corporation Information
12.5.2 Biogen, Inc. Description and Business Overview
12.5.3 Biogen, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Biogen, Inc. Nuclear Receptor ROR-Gamma Products Offered
12.5.5 Biogen, Inc. Recent Development
12.6 Brickell Biotech, Inc.
12.6.1 Brickell Biotech, Inc. Corporation Information
12.6.2 Brickell Biotech, Inc. Description and Business Overview
12.6.3 Brickell Biotech, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Products Offered
12.6.5 Brickell Biotech, Inc. Recent Development
12.7 Bristol-Myers Squibb Company
12.7.1 Bristol-Myers Squibb Company Corporation Information
12.7.2 Bristol-Myers Squibb Company Description and Business Overview
12.7.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Products Offered
12.7.5 Bristol-Myers Squibb Company Recent Development
12.8 Celgene Corporation
12.8.1 Celgene Corporation Corporation Information
12.8.2 Celgene Corporation Description and Business Overview
12.8.3 Celgene Corporation Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Celgene Corporation Nuclear Receptor ROR-Gamma Products Offered
12.8.5 Celgene Corporation Recent Development
12.9 Genentech, Inc.
12.9.1 Genentech, Inc. Corporation Information
12.9.2 Genentech, Inc. Description and Business Overview
12.9.3 Genentech, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Genentech, Inc. Nuclear Receptor ROR-Gamma Products Offered
12.9.5 Genentech, Inc. Recent Development
12.10 Genfit SA
12.10.1 Genfit SA Corporation Information
12.10.2 Genfit SA Description and Business Overview
12.10.3 Genfit SA Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Genfit SA Nuclear Receptor ROR-Gamma Products Offered
12.10.5 Genfit SA Recent Development
12.11 4SC AG
12.11.1 4SC AG Corporation Information
12.11.2 4SC AG Description and Business Overview
12.11.3 4SC AG Sales, Revenue and Gross Margin (2015-2020)
12.11.4 4SC AG Nuclear Receptor ROR-Gamma Products Offered
12.11.5 4SC AG Recent Development
12.12 Hanmi Pharmaceuticals, Co. Ltd.
12.12.1 Hanmi Pharmaceuticals, Co. Ltd. Corporation Information
12.12.2 Hanmi Pharmaceuticals, Co. Ltd. Description and Business Overview
12.12.3 Hanmi Pharmaceuticals, Co. Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Hanmi Pharmaceuticals, Co. Ltd. Products Offered
12.12.5 Hanmi Pharmaceuticals, Co. Ltd. Recent Development
12.13 Karo Bio AB
12.13.1 Karo Bio AB Corporation Information
12.13.2 Karo Bio AB Description and Business Overview
12.13.3 Karo Bio AB Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Karo Bio AB Products Offered
12.13.5 Karo Bio AB Recent Development
12.14 Lead Pharma Holding B.V.
12.14.1 Lead Pharma Holding B.V. Corporation Information
12.14.2 Lead Pharma Holding B.V. Description and Business Overview
12.14.3 Lead Pharma Holding B.V. Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Lead Pharma Holding B.V. Products Offered
12.14.5 Lead Pharma Holding B.V. Recent Development
12.15 Nuevolution AB
12.15.1 Nuevolution AB Corporation Information
12.15.2 Nuevolution AB Description and Business Overview
12.15.3 Nuevolution AB Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Nuevolution AB Products Offered
12.15.5 Nuevolution AB Recent Development
12.16 Phenex Pharmaceuticals AG
12.16.1 Phenex Pharmaceuticals AG Corporation Information
12.16.2 Phenex Pharmaceuticals AG Description and Business Overview
12.16.3 Phenex Pharmaceuticals AG Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Phenex Pharmaceuticals AG Products Offered
12.16.5 Phenex Pharmaceuticals AG Recent Development
12.17 Reata Pharmaceuticals, Inc.
12.17.1 Reata Pharmaceuticals, Inc. Corporation Information
12.17.2 Reata Pharmaceuticals, Inc. Description and Business Overview
12.17.3 Reata Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Reata Pharmaceuticals, Inc. Products Offered
12.17.5 Reata Pharmaceuticals, Inc. Recent Development
12.18 Teijin Pharma Limited
12.18.1 Teijin Pharma Limited Corporation Information
12.18.2 Teijin Pharma Limited Description and Business Overview
12.18.3 Teijin Pharma Limited Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Teijin Pharma Limited Products Offered
12.18.5 Teijin Pharma Limited Recent Development
12.19 Visionary Pharmaceuticals, Inc.
12.19.1 Visionary Pharmaceuticals, Inc. Corporation Information
12.19.2 Visionary Pharmaceuticals, Inc. Description and Business Overview
12.19.3 Visionary Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Visionary Pharmaceuticals, Inc. Products Offered
12.19.5 Visionary Pharmaceuticals, Inc. Recent Development
12.20 Vitae Pharmaceuticals, Inc.
12.20.1 Vitae Pharmaceuticals, Inc. Corporation Information
12.20.2 Vitae Pharmaceuticals, Inc. Description and Business Overview
12.20.3 Vitae Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Vitae Pharmaceuticals, Inc. Products Offered
12.20.5 Vitae Pharmaceuticals, Inc. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Nuclear Receptor ROR-Gamma Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Nuclear Receptor ROR-Gamma Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States Nuclear Receptor ROR-Gamma Market Insights, Forecast to 2026
List of TablesTable 1. Nuclear Receptor ROR-Gamma Market Segments
Table 2. Ranking of Global Top Nuclear Receptor ROR-Gamma Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of VPR-66
Table 5. Major Manufacturers of INV-17
Table 6. Major Manufacturers of GSK-2981278
Table 7. Major Manufacturers of BBI-6000
Table 8. Major Manufacturers of Others
Table 9. Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Nuclear Receptor ROR-Gamma Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Nuclear Receptor ROR-Gamma Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Nuclear Receptor ROR-Gamma Sales Market Share by Regions (2015-2020)
Table 13. Global Nuclear Receptor ROR-Gamma Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Nuclear Receptor ROR-Gamma Sales Forecast by Region (2021-2026) (K Pcs)
Table 15. Global Nuclear Receptor ROR-Gamma Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Nuclear Receptor ROR-Gamma Sales Share by Manufacturers (2015-2020)
Table 17. Global Nuclear Receptor ROR-Gamma Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Nuclear Receptor ROR-Gamma by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Receptor ROR-Gamma as of 2019)
Table 19. Nuclear Receptor ROR-Gamma Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Nuclear Receptor ROR-Gamma Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Nuclear Receptor ROR-Gamma Price (2015-2020) (USD/Pcs)
Table 22. Nuclear Receptor ROR-Gamma Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Nuclear Receptor ROR-Gamma Product Type
Table 24. Date of International Manufacturers Enter into Nuclear Receptor ROR-Gamma Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Nuclear Receptor ROR-Gamma Sales by Type (2015-2020) (K Pcs)
Table 27. Global Nuclear Receptor ROR-Gamma Sales Share by Type (2015-2020)
Table 28. Global Nuclear Receptor ROR-Gamma Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Nuclear Receptor ROR-Gamma Revenue Share by Type (2015-2020)
Table 30. Nuclear Receptor ROR-Gamma Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Nuclear Receptor ROR-Gamma Sales Share by Type (2021-2026)
Table 32. Global Nuclear Receptor ROR-Gamma Sales by Application (2015-2020) (K Pcs)
Table 33. Global Nuclear Receptor ROR-Gamma Sales Share by Application (2015-2020)
Table 34. Global Nuclear Receptor ROR-Gamma Sales Share by Application (2021-2026)
Table 35. Global Nuclear Receptor ROR-Gamma Sales Market Share Forecast by Application (2021-2026)
Table 36. Global Nuclear Receptor ROR-Gamma Revenue by Application (2015-2020) (US$ Million)
Table 37. Global Nuclear Receptor ROR-Gamma Revenue Market Share Forecast by Application (2021-2026)
Table 38. United States Nuclear Receptor ROR-Gamma Sales (K Pcs) of Key Companies (2015-2020)
Table 39. United States Nuclear Receptor ROR-Gamma Sales Share by Company (2015-2020)
Table 40. United States Nuclear Receptor ROR-Gamma Revenue (US$ Million) by Company (2015-2020)
Table 41. United States Nuclear Receptor ROR-Gamma Sales (K Pcs) by Type (2015-2020)
Table 42. United States Nuclear Receptor ROR-Gamma Sales Share by Type (2015-2020)
Table 43. United States Nuclear Receptor ROR-Gamma Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. United States Nuclear Receptor ROR-Gamma Price (K Pcs) by Type (2015-2020)
Table 45. United States Nuclear Receptor ROR-Gamma Sales (K Pcs) by Type (2021-2026)
Table 46. United States Nuclear Receptor ROR-Gamma Sales Share by Type (2021-2026)
Table 47. United States Nuclear Receptor ROR-Gamma Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. United States Nuclear Receptor ROR-Gamma Revenue Share by Type (2021-2026)
Table 49. United States Nuclear Receptor ROR-Gamma Price (K Pcs) by Type (2021-2026)
Table 50. United States Nuclear Receptor ROR-Gamma Sales (K Pcs) by Application (2015-2020)
Table 51. United States Nuclear Receptor ROR-Gamma Sales Share by Application (2015-2020)
Table 52. United States Nuclear Receptor ROR-Gamma Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. United States Nuclear Receptor ROR-Gamma Sales (K Pcs) by Application (2021-2026)
Table 54. United States Nuclear Receptor ROR-Gamma Sales Share by Application (2021-2026)
Table 55. United States Nuclear Receptor ROR-Gamma Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. United States Nuclear Receptor ROR-Gamma Revenue Share by Application (2021-2026)
Table 57. North America Nuclear Receptor ROR-Gamma Sales by Country (2015-2020) (K Pcs)
Table 58. North America Nuclear Receptor ROR-Gamma Sales Market Share by Country (2015-2020)
Table 59. North America Nuclear Receptor ROR-Gamma Revenue by Country (2015-2020) (US$ Million)
Table 60. North America Nuclear Receptor ROR-Gamma Revenue Market Share by Country (2015-2020)
Table 61. Europe Nuclear Receptor ROR-Gamma Sales by Country (2015-2020) (K Pcs)
Table 62. Europe Nuclear Receptor ROR-Gamma Sales Market Share by Country (2015-2020)
Table 63. Europe Nuclear Receptor ROR-Gamma Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe Nuclear Receptor ROR-Gamma Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific Nuclear Receptor ROR-Gamma Sales by Region (2015-2020) (K Pcs)
Table 66. Asia Pacific Nuclear Receptor ROR-Gamma Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific Nuclear Receptor ROR-Gamma Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific Nuclear Receptor ROR-Gamma Revenue Market Share by Region (2015-2020)
Table 69. Latin America Nuclear Receptor ROR-Gamma Sales by Country (2015-2020) (K Pcs)
Table 70. Latin America Nuclear Receptor ROR-Gamma Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa Nuclear Receptor ROR-Gamma Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America Nuclear Receptor ROR-Gamma Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Nuclear Receptor ROR-Gamma Sales by Country (2015-2020) (K Pcs)
Table 74. Middle East and Africa Nuclear Receptor ROR-Gamma Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue Market Share by Country (2015-2020)
Table 77. 4SC AG Corporation Information
Table 78. 4SC AG Description and Business Overview
Table 79. 4SC AG Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. 4SC AG Nuclear Receptor ROR-Gamma Product
Table 81. 4SC AG Recent Development
Table 82. Advinus Therapeutics Ltd. Corporation Information
Table 83. Advinus Therapeutics Ltd. Description and Business Overview
Table 84. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Advinus Therapeutics Ltd. Product
Table 86. Advinus Therapeutics Ltd. Recent Development
Table 87. Arrien Pharmaceuticals, LLC Corporation Information
Table 88. Arrien Pharmaceuticals, LLC Description and Business Overview
Table 89. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Arrien Pharmaceuticals, LLC Product
Table 91. Arrien Pharmaceuticals, LLC Recent Development
Table 92. Aurigene Discovery Technologies Limited Corporation Information
Table 93. Aurigene Discovery Technologies Limited Description and Business Overview
Table 94. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Aurigene Discovery Technologies Limited Product
Table 96. Aurigene Discovery Technologies Limited Recent Development
Table 97. Biogen, Inc. Corporation Information
Table 98. Biogen, Inc. Description and Business Overview
Table 99. Biogen, Inc. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Biogen, Inc. Product
Table 101. Biogen, Inc. Recent Development
Table 102. Brickell Biotech, Inc. Corporation Information
Table 103. Brickell Biotech, Inc. Description and Business Overview
Table 104. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Brickell Biotech, Inc. Product
Table 106. Brickell Biotech, Inc. Recent Development
Table 107. Bristol-Myers Squibb Company Corporation Information
Table 108. Bristol-Myers Squibb Company Description and Business Overview
Table 109. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Bristol-Myers Squibb Company Product
Table 111. Bristol-Myers Squibb Company Recent Development
Table 112. Celgene Corporation Corporation Information
Table 113. Celgene Corporation Description and Business Overview
Table 114. Celgene Corporation Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Celgene Corporation Product
Table 116. Celgene Corporation Recent Development
Table 117. Genentech, Inc. Corporation Information
Table 118. Genentech, Inc. Description and Business Overview
Table 119. Genentech, Inc. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Genentech, Inc. Product
Table 121. Genentech, Inc. Recent Development
Table 122. Genfit SA Corporation Information
Table 123. Genfit SA Description and Business Overview
Table 124. Genfit SA Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Genfit SA Product
Table 126. Genfit SA Recent Development
Table 127. GlaxoSmithKline Plc Corporation Information
Table 128. GlaxoSmithKline Plc Description and Business Overview
Table 129. GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. GlaxoSmithKline Plc Product
Table 131. GlaxoSmithKline Plc Recent Development
Table 132. Hanmi Pharmaceuticals, Co. Ltd. Corporation Information
Table 133. Hanmi Pharmaceuticals, Co. Ltd. Description and Business Overview
Table 134. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 135. Hanmi Pharmaceuticals, Co. Ltd. Product
Table 136. Hanmi Pharmaceuticals, Co. Ltd. Recent Development
Table 137. Karo Bio AB Corporation Information
Table 138. Karo Bio AB Description and Business Overview
Table 139. Karo Bio AB Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 140. Karo Bio AB Product
Table 141. Karo Bio AB Recent Development
Table 142. Lead Pharma Holding B.V. Corporation Information
Table 143. Lead Pharma Holding B.V. Description and Business Overview
Table 144. Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 145. Lead Pharma Holding B.V. Product
Table 146. Lead Pharma Holding B.V. Recent Development
Table 147. Nuevolution AB Corporation Information
Table 148. Nuevolution AB Description and Business Overview
Table 149. Nuevolution AB Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 150. Nuevolution AB Product
Table 151. Nuevolution AB Recent Development
Table 152. Phenex Pharmaceuticals AG Corporation Information
Table 153. Phenex Pharmaceuticals AG Description and Business Overview
Table 154. Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 155. Phenex Pharmaceuticals AG Product
Table 156. Phenex Pharmaceuticals AG Recent Development
Table 157. Reata Pharmaceuticals, Inc. Corporation Information
Table 158. Reata Pharmaceuticals, Inc. Description and Business Overview
Table 159. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 160. Reata Pharmaceuticals, Inc. Product
Table 161. Reata Pharmaceuticals, Inc. Recent Development
Table 162. Teijin Pharma Limited Corporation Information
Table 163. Teijin Pharma Limited Description and Business Overview
Table 164. Teijin Pharma Limited Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 165. Teijin Pharma Limited Product
Table 166. Teijin Pharma Limited Recent Development
Table 167. Visionary Pharmaceuticals, Inc. Corporation Information
Table 168. Visionary Pharmaceuticals, Inc. Description and Business Overview
Table 169. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 170. Visionary Pharmaceuticals, Inc. Product
Table 171. Visionary Pharmaceuticals, Inc. Recent Development
Table 172. Vitae Pharmaceuticals, Inc. Corporation Information
Table 173. Vitae Pharmaceuticals, Inc. Description and Business Overview
Table 174. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 175. Vitae Pharmaceuticals, Inc. Product
Table 176. Vitae Pharmaceuticals, Inc. Recent Development
Table 177. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 178. Key Challenges
Table 179. Market Risks
Table 180. Main Points Interviewed from Key Nuclear Receptor ROR-Gamma Players
Table 181. Nuclear Receptor ROR-Gamma Customers List
Table 182. Nuclear Receptor ROR-Gamma Distributors List
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Receptor ROR-Gamma Product Picture
Figure 2. Global Nuclear Receptor ROR-Gamma Sales Market Share by Type in 2020 & 2026
Figure 3. VPR-66 Product Picture
Figure 4. INV-17 Product Picture
Figure 5. GSK-2981278 Product Picture
Figure 6. BBI-6000 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Nuclear Receptor ROR-Gamma Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Nuclear Receptor ROR-Gamma Report Years Considered
Figure 13. Global Nuclear Receptor ROR-Gamma Market Size 2015-2026 (US$ Million)
Figure 14. Global Nuclear Receptor ROR-Gamma Sales 2015-2026 (K Pcs)
Figure 15. Global Nuclear Receptor ROR-Gamma Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Nuclear Receptor ROR-Gamma Sales Market Share by Region (2015-2020)
Figure 17. Global Nuclear Receptor ROR-Gamma Sales Market Share by Region in 2019
Figure 18. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Region (2015-2020)
Figure 19. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Region in 2019
Figure 20. Global Nuclear Receptor ROR-Gamma Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Nuclear Receptor ROR-Gamma Revenue in 2019
Figure 22. Nuclear Receptor ROR-Gamma Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Nuclear Receptor ROR-Gamma Sales Market Share by Type (2015-2020)
Figure 24. Global Nuclear Receptor ROR-Gamma Sales Market Share by Type in 2019
Figure 25. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2015-2020)
Figure 26. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type in 2019
Figure 27. Global Nuclear Receptor ROR-Gamma Market Share by Price Range (2015-2020)
Figure 28. Global Nuclear Receptor ROR-Gamma Sales Market Share by Application (2015-2020)
Figure 29. Global Nuclear Receptor ROR-Gamma Sales Market Share by Application in 2019
Figure 30. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2015-2020)
Figure 31. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Application in 2019
Figure 32. United States Nuclear Receptor ROR-Gamma Sales Growth Rate 2015-2026 (K Pcs)
Figure 33. United States Nuclear Receptor ROR-Gamma Revenue Growth Rate 2015-2026 (US$ Million)
Figure 34. United States Nuclear Receptor ROR-Gamma Market Share in Global Market 2015-2026
Figure 35. United States 5 and 10 Largest Nuclear Receptor ROR-Gamma Players Market Share by Revenue in Nuclear Receptor ROR-Gamma in 2019
Figure 36. United States Nuclear Receptor ROR-Gamma Revenue Share by Type (2015-2020)
Figure 37. United States Nuclear Receptor ROR-Gamma Revenue Growth Rate by Type in 2015 & 2019
Figure 38. United States Nuclear Receptor ROR-Gamma Revenue Share by Application (2015-2020)
Figure 39. United States Nuclear Receptor ROR-Gamma Revenue Growth Rate by Application in 2015 & 2019
Figure 40. North America Nuclear Receptor ROR-Gamma Sales Growth Rate 2015-2020 (K Pcs)
Figure 41. North America Nuclear Receptor ROR-Gamma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. North America Nuclear Receptor ROR-Gamma Sales Market Share by Country in 2019
Figure 43. North America Nuclear Receptor ROR-Gamma Revenue Market Share by Country in 2019
Figure 44. U.S. Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. U.S. Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Canada Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Canada Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Europe Nuclear Receptor ROR-Gamma Sales Growth Rate 2015-2020 (K Pcs)
Figure 49. Europe Nuclear Receptor ROR-Gamma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 50. Europe Nuclear Receptor ROR-Gamma Sales Market Share by Country in 2019
Figure 51. Europe Nuclear Receptor ROR-Gamma Revenue Market Share by Country in 2019
Figure 52. Germany Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Germany Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. France Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. France Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. U.K. Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. U.K. Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Italy Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. Italy Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Russia Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Russia Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Asia Pacific Nuclear Receptor ROR-Gamma Sales Growth Rate 2015-2020 (K Pcs)
Figure 63. Asia Pacific Nuclear Receptor ROR-Gamma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Nuclear Receptor ROR-Gamma Sales Market Share by Region in 2019
Figure 65. Asia Pacific Nuclear Receptor ROR-Gamma Revenue Market Share by Region in 2019
Figure 66. China Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. China Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Japan Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. South Korea Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. India Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Australia Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Taiwan Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Indonesia Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Thailand Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Malaysia Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Philippines Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 87. Vietnam Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Latin America Nuclear Receptor ROR-Gamma Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Nuclear Receptor ROR-Gamma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Nuclear Receptor ROR-Gamma Sales Market Share by Country in 2019
Figure 91. Latin America Nuclear Receptor ROR-Gamma Revenue Market Share by Country in 2019
Figure 92. Mexico Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Middle East and Africa Nuclear Receptor ROR-Gamma Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Nuclear Receptor ROR-Gamma Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue Market Share by Country in 2019
Figure 102. Turkey Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Porter's Five Forces Analysis
Figure 109. Nuclear Receptor ROR-Gamma Value Chain
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Bottom-up and Top-down Approaches for This Report
Figure 113. Data Triangulation
Figure 114. Key Executives Interviewed
Keyplayers in Global and United States Nuclear Receptor ROR-Gamma Market Insights, Forecast to 2026
4SC AGAdvinus Therapeutics Ltd.
Arrien Pharmaceuticals, LLC
Aurigene Discovery Technologies Limited
Biogen, Inc.
Brickell Biotech, Inc.
Bristol-Myers Squibb Company
Celgene Corporation
Genentech, Inc.
Genfit SA
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
Karo Bio AB
Lead Pharma Holding B.V.
Nuevolution AB
Phenex Pharmaceuticals AG
Reata Pharmaceuticals, Inc.
Teijin Pharma Limited
Visionary Pharmaceuticals, Inc.
Vitae Pharmaceuticals, Inc.